Thermo Fisher brings new automated sampling solution for VOC analysis
World | News | 0 Comment | 20 Mar, 2019
The Thermo Scientific TriPlus 500 Gas Chromatography Headspace Autosampler is designed for high sample through...Read more
Stanford Medicine announces results of unprecedented Apple Heart Study
World | News | 0 Comment | 19 Mar, 2019
Stanford Medicine has reported results of the Apple Heart Study, the largest study ever of its kind, which enrolled...Read more
EC approves Roche’s MabThera for a rare autoimmune disease
World | News | 0 Comment | 19 Mar, 2019
Roche announced that the European Commission has approved MabThera® (rituximab) for the treatment of adults with mod...Read more
Thermo Fisher to invest $150 M in expanding pharma services
World | News | 0 Comment | 19 Mar, 2019
Thermo Fisher Scientific Inc., the world leader in serving science, has announced that it is investing $150 million in i...Read more
Eppendorf presents extended spectrum of applications for centrifugation
World | News | 0 Comment | 19 Mar, 2019
Eppendorf has introduced the high-capacity fixed-angle Rotor FA-6x250 for up to 6 x 250 mL bottles. The Rotor FA-...Read more
World | News | 0 Comment | 18 Mar, 2019
ImmunogenX has announced the initiation of a Phase 2 clinical trial (named Celiac Shield), sponsored by the Nationa...Read more
Ortho's VITROS® XT MicroSlide receives CE Mark
World | News | 0 Comment | 18 Mar, 2019
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced it has received CE Mark for Ortho’s...Read more
Bionano Genomics enters into debt and equity financing agreements totaling $41.5m in commitments
World | News | 0 Comment | 18 Mar, 2019
Bionano Genomics, a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensiti...Read more
BD to market its Venovo™ Venous Stent
World | News | 0 Comment | 18 Mar, 2019
BD (Becton, Dickinson and Company), a leading global medical technology company, announced the U.S. Food and Drug Admini...Read more
Pharmaceutics International gets EIR from FDA
World | News | 0 Comment | 18 Mar, 2019
Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) has announced that...Read more
Alcon acquires PowerVision to make intraocular lens implants
World | News | 0 Comment | 18 Mar, 2019
Alcon, the global leader in eye care and a division of Novartis has acquired PowerVision, Inc., a privately-held, US-bas...Read more
USFDA approves new indication for valve repair device by Abbott
World | News | 0 Comment | 18 Mar, 2019
The U.S. Food and Drug Administration has approved a new indication for a heart valve repair device that is intended to ...Read more
World | News | 0 Comment | 15 Mar, 2019
Bayer presented results from the CHICO part (CHagas disease In Children treated with NifurtimOx) of the phase III clinic...Read more
Dornier launches Dornier OptiVision Next-Gen digital image processing technology
World | News | 0 Comment | 15 Mar, 2019
Dornier MedTech (Dornier), the global leader in stone management that pioneered Extracorporeal Shockwave Lithotripter (E...Read more
Hematogenix launches FDA approved companion diagnostic test for Triple-Negative Breast Cancer
World | News | 0 Comment | 15 Mar, 2019
Hematogenix, a global leader in the field of integrated pathology services for drug development and immuno-oncology test...Read more
Merck to use Generative Modelling AI technology
World | News | 0 Comment | 14 Mar, 2019
Merck, a leading science and technology company, has announced a collaboration agreement with Iktos, for the use of its ...Read more
Janssen seeks USFDA nod for Darzalex to treat ASCT multiple myeloma
World | News | 0 Comment | 14 Mar, 2019
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a supplemental Biologics Licen...Read more
Alvotech enrolls first patient for Ph III study involving Biosimilar version of HUMIRA
World | News | 0 Comment | 14 Mar, 2019
Global biopharmaceutical company Alvotech has announced that it has enrolled the first patient in its Phase III clinical...Read more